Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and Drug Administration (FDA).

East-West Shrine Bowl kicks off Thursday at AT&T Stadium. The annual meeting of some of the best college football players in ...

The East West Shrine Bowl in Arlington has a recognizable logo showing a football player and a little girl that goes back ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

A front-of-package food label would be a great educational tool. The Trump administration should keep it.

The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...

Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...

News-Medical speaks with Jordi Labs’ about its recent achievements, alignment with FDA expectations, and strategic ...